In the BioHarmony Drug Report Database
Cefiderocol
Fetroja, Fetcroja (cefiderocol) is a small molecule pharmaceutical. Cefiderocol was first approved as Fetroja on 2019-11-14. It is used to treat bacterial infections, pyelonephritis, and urinary tract infections in the USA. It has been approved in Europe to treat gram-negative bacterial infections. Fetroja’s patents are valid until 2035-09-03 (FDA).
Trade Name
|
Fetcroja |
|---|---|
Common Name
|
cefiderocol |
ChEMBL ID
|
CHEMBL3989974 |
Indication
|
bacterial infections, gram-negative bacterial infections, pyelonephritis, urinary tract infections |
Drug Class
|
Cephalosporins |
Image (chem structure or protein)